Label Changes for:

Isentress (raltegravir potassium) tablets

March 2010

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010

ADVERSE REACTIONS

Postmarketing Experience
  • Musculoskeletal and Connective Tissue Disorders: rhabdomyolysis
Hide
(web5)